Articles
For information related to a specific standard, enter the standard number in the search bar below. If no result is returned, contact your account advisor for guidance.
Maryland Halts New Licenses for Some Behavioral Health Programs
A moratorium on new licenses for select behavioral health programs and services in Maryland took effect July 1, 2024.
Heads Up, Laboratories! Dengue Virus, Novel Influenza, and More
On June 25, 2024, the U.S. Centers for Disease Control and Prevention (CDC) issued a Health Alert Network (HAN) message about an increased risk of dengue virus (DENV) infections in the United States in 2024.
U.S. Agencies Monitoring Avian Influenza While Measles and Mpox Demand Attention, Too
First, birds, of course. Then cows contracted A/H5 avian influenza. And now with a human case confirmed, the Centers for Disease Control and Prevention is taking steps to help manufacturers prepare to mass produce devices for testing. And in the U.S. and elsewhere, measles and Mpox require watching, too.
CMS Publishes Final Rule Updating CLIA Regulations
Centers for Medicare & Medicaid Services (CMS) has published final rule CMS-3326-F to update Clinical Laboratory Improvement Amendments of 1988 (CLIA) regulations. Topics include the CLIA fee and alternative sanctions, along with histocompatibility and personnel requirements.
CMS Changing CLIA Proficiency Testing Regulations
Staff and administrators of some clinical laboratories will have rules changes to keep up with in the months ahead as Clinical Laboratory Improvement Amendments (CLIA) proficiency testing regulations take effect.
Plan Ahead for Potential Drug Recalls
As drug recalls become more common, pharmacies should ensure they are prepared to effectively manage them and minimize risk for patients and their business.